SPRY Lowers Guidance
ARS Pharmaceuticals lowers FY26 cash operating expense guidance, shares trade lower
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
ARS Pharmaceuticals lowers FY26 cash operating expense guidance, shares trade lower
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.